Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The Market Ahead Goldman Sachs estimates the global obesity market will reach $95 billion by 2030, down from an earlier forecast of $130 billion, but still one of the largest market opportunities in the pharmaceutical sector today
Typically, a BMI of 30 or higher, or a BMI of 27 or higher with additional weight-related health concerns such as high blood pressure, type 2 diabetes, or elevated cholesterol, may indicate that you could benefit from weight-loss medications like tirzepatide
This makes tirzepatide stand out in performance when compared to other options like Ozempic
GLP-1 receptor agonists have emerged as powerful tools for weight loss, with several options now available on the market
US$ 22.10
US$ 27.03
US$ 25.68
US$ 27.42
